What is the association of renin–angiotensin–aldosterone system inhibitors with COVID-19 outcomes: retrospective study of racially diverse patients?

OBJECTIVE: To describe the clinical outcomes of COVID-19 in a racially diverse sample from the US Southeast and examine the association of renin–angiotensin–aldosterone system (RAAS) inhibitor use with COVID-19 outcome. DESIGN, SETTING, PARTICIPANTS: This study is a retrospective cohort of 1024 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Khodneva, Yulia, Malla, Gargya, Clarkson, Stephen, Fu, Richard, Safford, Monika M, Goyal, Parag, Oparil, Suzanne, Cherrington, Andrea L, Jackson, Elizabeth A, Willig, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006195/
https://www.ncbi.nlm.nih.gov/pubmed/35414547
http://dx.doi.org/10.1136/bmjopen-2021-053961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006195/
https://www.ncbi.nlm.nih.gov/pubmed/35414547
http://dx.doi.org/10.1136/bmjopen-2021-053961

Ejemplares similares